Collegium Pharmaceutical Inc (COLL)
29.96
-0.45
(-1.48%)
USD |
NASDAQ |
Nov 22, 16:00
29.92
-0.04
(-0.13%)
After-Hours: 20:00
Collegium Pharmaceutical Cash from Investing (Quarterly): -248.96M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -248.96M |
| June 30, 2024 | -8.906M |
| March 31, 2024 | -18.13M |
| December 31, 2023 | -25.10M |
| September 30, 2023 | -3.822M |
| June 30, 2023 | -41.72M |
| March 31, 2023 | -0.176M |
| December 31, 2022 | -0.94M |
| September 30, 2022 | -0.113M |
| June 30, 2022 | -0.461M |
| March 31, 2022 | -572.18M |
| December 31, 2021 | -0.515M |
| September 30, 2021 | -0.276M |
| June 30, 2021 | -0.725M |
| March 31, 2021 | -0.428M |
| December 31, 2020 | -1.481M |
| September 30, 2020 | -2.403M |
| June 30, 2020 | -2.241M |
| March 31, 2020 | -367.65M |
| December 31, 2019 | -0.889M |
| September 30, 2019 | -1.351M |
| June 30, 2019 | -0.875M |
| Date | Value |
|---|---|
| March 31, 2019 | -3.323M |
| December 31, 2018 | -1.773M |
| September 30, 2018 | -2.717M |
| June 30, 2018 | -0.747M |
| March 31, 2018 | -19.12M |
| December 31, 2017 | -0.172M |
| September 30, 2017 | -0.34M |
| June 30, 2017 | -0.449M |
| March 31, 2017 | -0.029M |
| December 31, 2016 | -0.341M |
| September 30, 2016 | -0.111M |
| June 30, 2016 | -2.525M |
| March 31, 2016 | |
| December 31, 2015 | -0.187M |
| September 30, 2015 | -0.152M |
| June 30, 2015 | -0.023M |
| March 31, 2015 | |
| December 31, 2014 | -0.008M |
| September 30, 2014 | |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-572.18M
Minimum
Mar 2022
-0.113M
Maximum
Sep 2022
-64.86M
Average
-1.861M
Median
Cash from Investing (Quarterly) Benchmarks
| Amicus Therapeutics Inc | 34.27M |
| Insmed Inc | -1.003B |
| Pulmonx Corp | 6.751M |
| RxSight Inc | -9.26M |
| Context Therapeutics Inc | -14.76M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -8.999M |
| Cash from Financing (Quarterly) | 149.03M |
| Free Cash Flow | 192.43M |
| Free Cash Flow Per Share (Quarterly) | -0.2301 |
| Free Cash Flow to Equity (Quarterly) | -323.62M |
| Free Cash Flow to Firm (Quarterly) | -0.1872M |
| Free Cash Flow Yield | 13.99% |